Literature DB >> 26447065

Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.

W O Tobin1, B F Popescu2, V Lowe3, I Pirko1, J E Parisi4, K Kantarci3, J A Fields5, M B Bruns1, B F Boeve1, C F Lucchinetti6.   

Abstract

BACKGROUND AND OBJECTIVES: We report a comprehensive clinical, radiological, neuropsychometric and pathological evaluation of a woman with a clinical diagnosis of AD dementia (ADem), but whose autopsy demonstrated widespread demyelination, without Alzheimer disease (AD) pathology. METHODS AND
RESULTS: Initial neuropsychometric evaluation suggested amnestic mild cognitive impairment (aMCI). Serial magnetic resonance images (MRI) images demonstrated the rate of increase in her ventricular volume was comparable to that of 46 subjects with aMCI who progressed to ADem, without accumulating white matter disease. Myelin immunohistochemistry at autopsy demonstrated extensive cortical subpial demyelination. Subpial lesions involved the upper cortical layers, and often extended through the entire width of the cortex.
CONCLUSIONS: Multiple sclerosis (MS) can cause severe cortical dysfunction and mimic ADem. Cortical demyelination is not well detected by standard imaging modalities and may not be detected on autopsy without myelin immunohistochemistry.
© The Author(s), 2015.

Entities:  

Keywords:  Cortical demyelination; cognitive impairment; multiple sclerosis

Mesh:

Year:  2015        PMID: 26447065      PMCID: PMC4808389          DOI: 10.1177/1352458515604382

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  21 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.

Authors:  C T Bever; L Grattan; H S Panitch; K P Johnson
Journal:  Mult Scler       Date:  1995-11       Impact factor: 6.312

4.  Multiple sclerosis with predominant, severe cognitive impairment.

Authors:  Nathan P Staff; Claudia F Lucchinetti; B Mark Keegan
Journal:  Arch Neurol       Date:  2009-09

5.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

Authors:  Lars Bö; Jeroen J G Geurts; Paul van der Valk; Chris Polman; Frederik Barkhof
Journal:  Arch Neurol       Date:  2007-01

6.  Ten-year risk of dementia in subjects with mild cognitive impairment.

Authors:  Pieter Jelle Visser; Arnold Kester; Jellemer Jolles; Frans Verhey
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

7.  Abnormal tau phosphorylation in primary progressive multiple sclerosis.

Authors:  Jane Marian Anderson; Rickie Patani; Richard Reynolds; Richard Nicholas; Alastair Compston; Maria Grazia Spillantini; Siddharthan Chandran
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

8.  Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?

Authors:  Alexandra Kutzelnigg; Hans Lassmann
Journal:  J Neurol Sci       Date:  2006-05-02       Impact factor: 3.181

9.  Multiple sclerosis and Alzheimer's disease.

Authors:  Assunta Dal Bianco; Monika Bradl; Josa Frischer; Alexandra Kutzelnigg; Kurt Jellinger; Hans Lassmann
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

10.  Atrophy rates accelerate in amnestic mild cognitive impairment.

Authors:  C R Jack; S D Weigand; M M Shiung; S A Przybelski; P C O'Brien; J L Gunter; D S Knopman; B F Boeve; G E Smith; R C Petersen
Journal:  Neurology       Date:  2007-11-21       Impact factor: 9.910

View more
  11 in total

1.  DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia.

Authors:  Kai-Hei Tse; Aifang Cheng; Fulin Ma; Karl Herrup
Journal:  Alzheimers Dement       Date:  2018-01-09       Impact factor: 21.566

Review 2.  Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.

Authors:  Farzaneh A Sorond; Shawn Whitehead; Ken Arai; Douglas Arnold; S Thomas Carmichael; Charles De Carli; Marco Duering; Myriam Fornage; Rafael E Flores-Obando; Jonathan Graff-Radford; Edith Hamel; David C Hess; Massafumi Ihara; Majken K Jensen; Hugh S Markus; Axel Montagne; Gary Rosenberg; Andy Y Shih; Eric E Smith; Alex Thiel; Kai Hei Tse; Donna Wilcock; Frank Barone
Journal:  Geroscience       Date:  2019-12-06       Impact factor: 7.713

3.  Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis.

Authors:  Diana P Londoño; Kogulavadanan Arumaithurai; Eleni Constantopoulos; Michael R Basso; R Ross Reichard; Eoin P Flanagan; B Mark Keegan
Journal:  Brain Commun       Date:  2022-06-22

Review 4.  Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.

Authors:  Hsueh-Sheng Chiang; Alka Khera; Barbara E Stopschinski; Olaf Stuve; John Hart; Brendan Kelley; Trung Nguyen
Journal:  Geriatrics (Basel)       Date:  2022-06-05

5.  Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.

Authors:  Lynn van Olst; Carla Rodriguez-Mogeda; Carmen Picon; Svenja Kiljan; Rachel E James; Alwin Kamermans; Susanne M A van der Pol; Lydian Knoop; Iliana Michailidou; Evelien Drost; Marc Franssen; Geert J Schenk; Jeroen J G Geurts; Sandra Amor; Nicholas D Mazarakis; Jack van Horssen; Helga E de Vries; Richard Reynolds; Maarten E Witte
Journal:  Acta Neuropathol       Date:  2021-03-29       Impact factor: 17.088

6.  Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions.

Authors:  Bogdan F Popescu; Josa M Frischer; Samuel M Webb; Mylyne Tham; Reginald C Adiele; Christopher A Robinson; Patrick D Fitz-Gibbon; Stephen D Weigand; Imke Metz; Susan Nehzati; Graham N George; Ingrid J Pickering; Wolfgang Brück; Simon Hametner; Hans Lassmann; Joseph E Parisi; Guo Yong; Claudia F Lucchinetti
Journal:  Acta Neuropathol       Date:  2017-03-22       Impact factor: 17.088

7.  Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis.

Authors:  Magdalena Kolanko; Zarni Win; Neva Patel; Omar Malik; Christopher Carswell; Anastassia Gontsarova; Richard Nicholas; Richard Perry; Paresh Malhotra
Journal:  J Neurol       Date:  2020-06-18       Impact factor: 4.849

Review 8.  CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?

Authors:  Zorica Stojić-Vukanić; Senka Hadžibegović; Olivier Nicole; Mirjana Nacka-Aleksić; Sanja Leštarević; Gordana Leposavić
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

9.  Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.

Authors:  Junjun Sun; Hong Zhou; Feng Bai; Qingguo Ren; Zhijun Zhang
Journal:  Oncotarget       Date:  2016-05-24

10.  Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.

Authors:  Burcu Zeydan; Val J Lowe; Ross R Reichard; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Joseph E Parisi; Mary M Machulda; Prashanthi Vemuri; Michelle M Mielke; David S Knopman; Ronald C Petersen; Clifford R Jack; Orhun H Kantarci; Kejal Kantarci
Journal:  Ann Neurol       Date:  2020-02-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.